Multinational health and pharmaceutical giants
GlaxoSmithKline (GSK),
Teva and Takeda
have partnered with EcoVadis — the leading provider of sustainability risk
and performance ratings for global supply chains — to launch the Responsible
Health Initiative (RHI). The
mission of the new initiative is to collaborate on technologies to improve the
visibility, efficiency and sustainability impacts of the global health supply
chain.
“As business models across the health and pharmaceutical industries continue to
evolve and overlap, it makes sense for organizations to focus on shared needs,
goals and opportunities in sustainability, and act on them through the
collective industry supply chain,” said Pierre-Francois Thaler, co-CEO and
co-founder of EcoVadis. “Peer collaboration is a proven model for enabling
companies in any sector to easily harmonize sustainability performance
measurement and extend visibility. We are confident the Responsible Health
Initiative will help create the networked impact the healthcare industry needs.”
The effort will increase shared value across the industry’s supply chain by
enabling key players in the global health sector to boost not only their own
sustainability performance, but also that of the industry’s collective group of
suppliers. The initiative will be powered by EcoVadis’ platform and scalable
methodology, which offers deeper transparency and insight into supply chain
corporate social responsibility practices.
RHI marks the sixth sector collaborative managed by EcoVadis and will take
learning from these other collaborations — Together for Sustainability,
Railsponsible,
AIM-Progress, the Joint Audit Cooperation and the Responsible Beauty
Initiative
— into account.
The shared vision for the Responsible Health Initiative includes:
-
Harmonizing industry standards for online CSR assessments, with reliable
indicators and global benchmarks
-
Adopting a common platform to ease sharing of CSR performance among
suppliers/third parties and RHI members
-
Implementing shared tools to boost supplier engagement and improvement
plans
-
Working together to reduce risk and increase visibility in the supply
chain
Members of the RHI will be equipped to access untapped sustainability potential
across the industry supply chain, identify high-performing suppliers and best
practices, reduce operational disruptions, mitigate risk and drive value with
suppliers.
“Being part of the Responsible Health Initiative will help us leverage digital
sustainability intelligence to more effectively select and partner with
suppliers who share our values,” said Val Monk, Head of Ethics and Risk
Programs at GSK.
Get the latest insights, trends, and innovations to help position yourself at the forefront of sustainable business leadership—delivered straight to your inbox.
Published Jan 9, 2019 7pm EST / 4pm PST / 12am GMT / 1am CET